5,10,15,20-Tetrakis(3,5-dihydroxyphenyl)porphyrin, 90%, 250mg

4-Fluorophenoxyacetic acid, 98.0%, 25g

Recipientes esterilizables en autoclave con tapa rectangular, 42 l, 1 unidad

(2S,3R,4R,5S,6R)-2-(4-CHLORO-3-(4-ETHOXYBENZYL)PHENYL)-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL COMPOUND WITH (S)-PROPANE-1,2-DIOL (1:1) HYDRATE, 95%, 250mg

Óxido de plata, mínimo 99 %, pa, 50 g, envase de vidrio

Succinic acid, 99.0%, 100g

2,2-Bis(2-chlorophenyl)-2-hydroxyacetic acid, 98%, 100mg

n-Heptano, mínimo 95 %, para síntesis, 2,5 l, envase de vidrio

(4-CHLORO-THIAZOL-2-YL)ACETIC ACID, 95.0%, 10g

1-Bromo-2-(cyclopentyloxy)benzene, 96%, 10g

Benzyl thiocyanate, 98.0%, 25g

Oseltamivir acid, 25mg

Methyl 4-chloro-1H-indole-2-carboxylate, 95.0%, 100mg